Literature DB >> 9652413

Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein.

A B Shapiro1, V Ling.   

Abstract

In order to describe the transport mechanism of P-glycoprotein, it is essential to know the coupling ratio, i.e. the moles substrate transported/mole ATP hydrolyzed. P-glycoprotein couples ATP hydrolysis at two ATP-binding sites to transport of a wide variety of neutral or cationic lipophilic compounds. Previously published coupling ratios have fallen within the range 0.02-0.8 mol substrate transported/mol ATP hydrolyzed. We studied the energetics of transport by P-glycoprotein, performing quantitative measurements of the rates of ATP hydrolysis and transport of rhodamine 123 by P-glycoprotein, using isolated P-glycoprotein-rich plasma membrane vesicles. The continuous fluorescence-based assay of rhodamine 123 transport allowed accurate measurement of initial transport rates. Since we measured uptake of rhodamine 123 into the vesicles as a loss of fluorescence, we avoided the problem of high background due to substrate binding to the membranes. The coupling ratio of the transport reaction increased as the rhodamine 123 concentration increased, showing that the basal ATPase activity of P-glycoprotein was progressively recruited for rhodamine 123 transport. Both of the previously identified transport sites of P-glycoprotein [Shapiro, A. B. & Ling, V. (1997a) Eur J. Biochem. 250, 130-137] were involved in transport of saturating concentrations of rhodamine 123. At saturating rhodamine 123 and 0.3 mM ATP, the coupling ratio was 0.83, suggesting a mechanistic coupling ratio of 1. Interestingly, the coupling ratio decreased as the ATP concentration increased so that, at 1.5 mM, close to the cytoplasmic concentration of ATP, the coupling ratio was 0.57. The physiological significance of this effect is not yet understood.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652413     DOI: 10.1046/j.1432-1327.1998.2540189.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  Inhibition of P-glycoprotein transport function by grapefruit juice psoralen.

Authors:  E J Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

2.  HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.

Authors:  E Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).

Authors:  Alexandra Orchard; Gregory A Schamerhorn; Brandon D Calitree; Geri A Sawada; Tip W Loo; M Claire Bartlett; David M Clarke; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2012-06-07       Impact factor: 3.641

4.  Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.

Authors:  Balram Chowbay; Huihua Li; Machin David; Yin Bun Cheung; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

Review 5.  The mechanism of action of multidrug-resistance-linked P-glycoprotein.

Authors:  Z E Sauna; M M Smith; M Müller; K M Kerr; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

6.  Interaction of common azole antifungals with P glycoprotein.

Authors:  Er-jia Wang; Karen Lew; Christopher N Casciano; Robert P Clement; William W Johnson
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 7.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?

Authors:  Francisco S Chung; Jayson S Santiago; Miguel Francisco M De Jesus; Camille V Trinidad; Melvin Floyd E See
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

9.  Establishment of a P-glycoprotein substrate screening model and its preliminary application.

Authors:  Yi Wang; Jiang Cao; Su Zeng
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

10.  Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

Authors:  Michael K Gannon; Jason J Holt; Stephanie M Bennett; Bryan R Wetzel; Tip W Loo; M Claire Bartlett; David M Clarke; Geri A Sawada; J William Higgins; Gregory Tombline; Thomas J Raub; Michael R Detty
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.